CVD single crystal diamond material

Details for Australian Patent Application No. 2011206524 (hide)

Owner Element Six Limited

Inventors Friel, Ian; Geoghegan, Sarah Louise; Twitchen, Daniel James; Dodson, Joseph Michael

Agent Davies Collison Cave

Pub. Number AU-A-2011206524

PCT Pub. Number WO2011/086164

Priority 1000768.0 18.01.10 GB

Filing date 14 January 2011

Wipo publication date 21 July 2011

International Classifications

C30B 29/04 Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape - Diamond

C23C 16/27 Chemical deposition or plating by decomposition

C30B 25/02 Single-crystal growth by chemical reaction of reactive gases, e.g. chemical vapour deposition growth - Epitaxial-layer growth

C30B 25/16 Single-crystal growth by chemical reaction of reactive gases, e.g. chemical vapour deposition growth - Controlling or regulating

F16D 65/06 Parts or details of brakes

F16D 69/04 Friction linings

H01S 3/30 Lasers, i.e. devices for generation, amplification, modulation, demodulation, or frequency-changing, using stimulated emission, of infra-red, visible, or ultra-violet waves - using scattering effects, e.g. stimulated Brillouin or Raman effects

B60T 1/06 Arrangements of braking elements, i.e. of those parts where braking effect occurs

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/086164 Priority application(s): WO2011/086164

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011206532-Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBD)

2011206475-5-oxo-5, 8-dihydropyrido [2, 3-d] pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases